Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RHYTHM: Recombinant LH vs hCG in Hypogonadotropic Hypogonadism
NCT04189133Phase 2Recruiting
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Jan 2022
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lutropin alfa in hypogonadotropic hypogonadism (HH), sponsored by Azienda Ospedaliera Universitaria Policlinico. Started Jan 2022; status: recruiting.
02
Drugs
lutropin alfa
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT04189133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189133.